Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 13/20 | 1.00 |
| ▸ | DPP4 | P27487 | 4/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 1.00 |
| ▸ | IDH1 | O75874 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | UGT1A1 | P22309 | 1/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 1/20 | 1.00 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 1.00 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.60 |
| ▸ | CTSL | P07711 | 1/20 | 0.60 |
| ▸ | CTSB | P07858 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Licoagrochacone A SCHEMBL29929441 | 1.00 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| Licoagrochacone A SCHEMBL4906294 | 1.00 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| Licoagrochacone A SCHEMBL114042 | 1.00 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL24026322 | 0.92 | PTPN1 (0.85) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7191524 | 0.92 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7191527 | 0.92 | PTPN1 (1.00) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| Licoagrochacone A SCHEMBL25196053 | 0.89 | PTPN1 (0.80) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7187524 | 0.88 | PTPN1 (0.79) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7187519 | 0.88 | PTPN1 (0.79) | PTPN1DPP4ABCG2IDH1ABCB1 | |
| SCHEMBL7178841 | 0.88 | PTPN1 (0.78) | PTPN1DPP4ABCG2IDH1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | PTPN1 1308/4885DPP4 4226/4885ABCG2 1606/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | PTPN1 1520/4885DPP4 3670/4885ABCG2 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.